CHINA SXT PHARMACEUTICALS IN (SXTC) Stock Analyst Earnings Estimates
NASDAQ:SXTC - Nasdaq - VGG2161P1403 - Common Stock
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | ||
|---|---|---|---|---|
| Revenue YoY % growth | 2.6M -45.61% | 1.97M -24.23% | 1.929M -2.11% | |
| EBITDA YoY % growth | -4.87M -163.24% | -5.01M -2.87% | -1.889M 62.29% | |
| EBIT YoY % growth | -5.19M -135.91% | -5.26M -1.35% | -2.092M 60.22% | |
| Operating Margin | -199.62% | -267.01% | -108.49% | |
| EPS YoY % growth | N/A | N/A | N/A |
All data in USD
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2024 Q2Q % growth | 988.91K 30.12% | % | ||
| Q2 2024 Q2Q % growth | 939.58K -22.35% | % | ||
| Q4 2023 Q2Q % growth | 760K -51.59% | % | ||
| Q2 2023 Q2Q % growth | 1.21M 17.48% | % | ||
| Q4 2022 Q2Q % growth | 1.57M 70.65% | % | ||
| Q2 2022 Q2Q % growth | 1.03M -73.32% | % | ||
| Q4 2021 Q2Q % growth | 920K -52.82% | % | ||
| Q2 2021 Q2Q % growth | 3.86M 19.88% | % | ||
| Q4 2020 Q2Q % growth | 1.95M -36.89% | % | ||
| Q2 2020 Q2Q % growth | 3.22M -17.86% | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A |
| Revenue | N/A | N/A | N/A | N/A |